MedTrace Logo

A Prospective, Randomized, Double-Masked, Single Center, Clinical Comparison of the Use of Systane Ultra in the Management of Dry Eyes in Bilateral Eyes

NCT00781092 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2012-09-20

No results posted yet for this study

Summary

The primary objective of this study is to compare two post operative drop regimens for the management of dry eye and control of healing using FDA-approved ophthalmic solutions.

Conditions

  • Dry Eye

Interventions

OTHER

Systane Ultra

Ophthalmic Solution, 1 gtt, three times daily to both eyes for 1 month post operative

OTHER

Bausch and Lomb Sensitive Eyes

Ophthalmic Solution, 1 gtt, three times a day in both eyes for 1 month after LASIK

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • Durrie Vision

    lead OTHER

Principal Investigators

  • Daniel S. Durrie, MD · Durrie Vision

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-03-31
Completion
2009-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00781092 on ClinicalTrials.gov